In her article, Julia Belluz examines the rising use of GLP-1 weight loss drugs in children with obesity and the ethical concerns surrounding their long-term effects, arguing that while these medications may provide immediate health benefits, they highlight a deeper societal failure to address the unhealthy food environment that contributes to childhood obesity. #ChildhoodObesity #HealthAndNutrition #GLP1 #US #CA #LA
www.nytimes.com
Opinion | If Kids Need GLP-1s, We've Already Let Them Down
Ms. Belluz is a contributing Opinion writer covering health, nutrition and chronic illness.
When Dr. Aaron Kelly began studying the effects of GLP-1 weight loss drugs in children with obesity, he thought it would be difficult to recruit patients.